Researchers from Florida Atlantic University and Harvard Medical School address the possible but unproven link between statins and diabetes, as well as the implications of prescription of statins for clinicians and their patients. They emphasize that the risk of diabetes, even if real, pales in comparison to the benefits of statins in both the treatment and primary prevention of heart attacks and strokes. The editor-in-chief published the commentary and his editorial online ahead of print.